Multidisciplinary Shared Decision Making of Fertility Preservation in Young Women With Breast Cancer

MedicalExcellence1 site in 1 country4,100 target enrollmentDecember 2021

ConditionsYoung Womenwith Breast Cancer

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Young Womenwith Breast Cancer
Sponsor: MedicalExcellence
Enrollment: 4100
Locations: 1
Primary Endpoint: selection ratio of fertility preservation procedure
Status: Not yet recruiting
Last Updated: 4 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

Multidisciplinary shared decision making of fertility preservation in Young womenwith Breast Cancer (MYBC): A Pragmatic stepped wedge cluster randomised trial

Registry

clinicaltrials.gov

Start Date

December 2021

End Date

December 2028

Last Updated

4 years ago

Study Type

Interventional

Study Design

Parallel

Sex

Female

Investigators

Sponsor

MedicalExcellence

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Women aged 19 to 40 years old
•A person diagnosed with breast cancer by biopsy
•Those who don't have evidence of distant metastasis
•Eastern Cooperative Oncology Group(ECOG) performance status: 0-2 score
•Before registering for clinical trials, chemotherapy, radiation therapy, anti-hormone therapy, immunotherapy, and surgery are not performed
•A person who has fully understood and listened to the explanation of this clinical trial and then gave written consent

Exclusion Criteria

•Histologically, a person diagnosed with follicular or sarcoma
•Those with a history of breast cancer (including recurrent breast cancer)
•A person diagnosed with another cancer before breast cancer
•A person diagnosed with metastatic breast cancer
•A person who has a mental illness and has a hard time understanding clinical trials
•Those who plan to conduct follow-up observation elsewhere(to change of hometowm)
•Menopausal factors without menstruation after more than a year from the last menstrual date
•A pregnant woman
•Inappropriate for participation in clinical trials